North America house of the year: JP Morgan

Structured Products Americas Awards 2017: Reliable yet innovative US behemoth won over customers and judges with an exceptional second half of the year

Larry Wilson of JP Morgan
Larry Wilson, JP Morgan

The year of 2016 was a game of two halves for JP Morgan. In the first half of the year, market conditions and regulatory uncertainty produced little of consequence; in the second, thanks to an organisational reshuffle and a more propitious climate, the US bank marched to glory in the structured products market. 

Over that six-month period, JP Morgan’s pace of retail issuance roughly doubled from its level during the first half of the year. The increase was driven partly by market rebounds but also followed the launch of an issuing entity – JP Morgan Chase Financial – to cope with the imposition of new total loss-absorbing capacity (TLAC) rules. That the novel issuing entity was able to achieve such overnight acceptance by investors is no mean feat.

In brief, the TLAC regulations seek to restrict the amount of non-TLAC debt that can be issued by global systemically important banks. Only a limited amount of non-TLAC debt can be outstanding by the time the rules come into effect on January 1, 2019. As even the most innocuous structured notes – apart from the most lightly structured rate linkers – are categorised as non-TLAC, this left JP Morgan with a problem. 

“Through 2015 it was quite apparent that we would have to come up with a way to manage the coming TLAC regulations. It was clear that it would be prudent to have an additional issuing entity for SEC-registered notes,” says Daniel Roose, an executive director in the Americas cross-asset structuring team in New York. 

Determining the shape and structure of the new legal entity was no easy task. The bank spent a long time evaluating the framework that would be optimal for itself and its clients, explains Roose. Fully guaranteed by JP Morgan Chase, JP Morgan Chase Financial, whose sole purpose is the issuance of debt, began printing securities in April 2016.

The firm issues only SEC-registered notes, and in 2016 it was the second most-prolific issuer, despite its late start. By the end of the year, it stood behind only UBS and had a 10.87% market share, representing 1,198 notes in all asset classes. In third place was JP Morgan Chase, with a market share of 10.37%. 

No-one would argue that 2016 was a halcyon period for the issuance of structured notes, particularly in the rates sector. Interest rates were firmly anchored at the foot of the table for most of the year, until the US election livened things up a little. In the face of a broad decline in the sale of structured notes across the market, JP Morgan’s issuance decreased by 7% while retail sales actually increased by 4%.

“We are committed to the business. We have breadth and depth across asset classes,” says Larry Wilson, the bank’s New York-based managing director in equity derivatives sales for North America.

Our goal is to be consistently relevant to our clients

Larry Wilson, JP Morgan

JP Morgan has been active in the structured notes business in the US for 20 years, and clients are happy to pay testimony to the bank’s strength and consistency. 

“Qualitatively, their staff are exceptional and have enjoyed very low turnover, allowing them a deep connectivity with our team; this results in JP Morgan continuously being our ‘gold standard’ in areas like idea generation, service level, etc. It is competitive in virtually every type of structure supporting both our onshore and offshore demand,” says the head of the solutions desk at a tier-one account. 

Several clients also noted that the bank seemed to find another gear in 2016. “JP Morgan has expanded its monthly offering from around 20 or 30 deals a few years ago to more than 50 today. Far from adding offerings simply for the sake of it, virtually all of its Cusips represent differentiated ideas and, as a result, garner worthwhile interest,” says one.

For example, despite the crushingly low rates environment last year, the bank remained present and continued to offer new ideas in the structured rates sector. It sold curve steepeners and hybrid steepeners that incorporated equity risk, and was the first bank to bring to the market short-dated yield notes linked to the 10-year constant maturity swap in an SEC-registered offering. These were targeted at buyers of structured equity notes as the payout mirrored those found in the equities market, with features such as reverse exchangeables and phoenix autocalls.

In the fourth quarter, JP Morgan also brought out its first structured note that was eligible as a qualified replacement property (QRP). Owners of retirement plans in the US can avoid the negative tax consequences of selling shares to an employee stock ownership plan if they reinvest the proceeds into a vehicle deemed a QRP

It is not easy to issue debt that qualifies as a QRP. The rules are complicated and most notes that are issued tend to be long dated in order to maximise tax efficiency. This has restricted the amount of QRP-eligible issuers to a small cast of institutions and has led, in turn, to an unwelcome concentration of credit.

JP Morgan saw the opportunity for new blood in this space. Following extensive internal collaboration and discussions with clients and partners, it printed the $100 million single-tranche issue in October.  

The bank demonstrated plenty of innovation during 2016, but it is JP Morgan’s determination to have a strong and nuanced presence across asset classes and products that is perhaps even more worthy of note. 

“Our goal is to be consistently relevant to our clients,” stresses Wilson.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here